Answer
Ontozry (cenobamate) is indicated as adjunctive treatment for focal-onset seizures, with or without secondary generalisation, in adults with epilepsy inadequately controlled despite treatment with at least two anti-epileptic medicines.
Sources for this answer
- Ontozry 200 mg film-coated tabletsAngelini Pharma UK-I Limited (Formerly Arvelle Therapeutics UK) · emc · SmPC §4.1 Therapeutic Indications · Version 8Document updated
Sources checked